The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells - PubMed

Affiliations

• PMID: 18156156
• DOI: 10.1093/brain/awm295

The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells

Igal Ifergan et al. Brain. 2008 Mar.

Abstract

Trafficking of antigen-presenting cells into the CNS is essential for lymphocyte reactivation within the CNS compartment. Although perivascular dendritic cells found in inflammatory lesions are reported to polarize naive CD4+ T lymphocytes into interleukin-17-secreting-cells, the origin of those antigen-presenting cells remains controversial. We demonstrate that a subset of CD14+ monocytes migrate across the inflamed human blood-brain barrier (BBB) and differentiate into CD83+CD209+ dendritic cells under the influence of BBB-secreted transforming growth factor-beta and granulocyte-macrophage colony-stimulating factor. We also demonstrate that these dendritic cells secrete interleukin-12p70, transforming growth factor-beta and interleukin-6 and promote the proliferation and expansion of distinct populations of interferon-gamma-secreting Th1 and interleukin-17-secreting Th17 CD4+ T lymphocytes. We further confirmed the abundance of such dendritic cells in situ, closely associated with microvascular BBB-endothelial cells within acute multiple sclerosis lesions, as well as a significant number of CD4+ interleukin-17+ T lymphocytes in the perivascular infiltrate. Our data support the notion that functional perivascular myeloid CNS dendritic cells arise as a consequence of migration of CD14+ monocytes across the human BBB, through the concerted actions of BBB-secreted transforming growth factor-beta and granulocyte-macrophage colony-stimulating factor.

Similar articles

• Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli.

  Bechetoille N, André V, Valladeau J, Perrier E, Dezutter-Dambuyant C. Bechetoille N, et al. J Leukoc Biol. 2006 Jul;80(1):45-58. doi: 10.1189/jlb.0205109. Epub 2006 Apr 13. J Leukoc Biol. 2006. PMID: 16614258

• Monocytes immunoselected via the novel monocyte specific molecule, CD300e, differentiate into active migratory dendritic cells.

  Clark GJ, Jamriska L, Rao M, Hart DN. Clark GJ, et al. J Immunother. 2007 Apr;30(3):303-11. doi: 10.1097/01.cji.0000211342.65964.9e. J Immunother. 2007. PMID: 17414321

• Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.

  Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G, Rivoltini L. Valenti R, et al. Cancer Res. 2006 Sep 15;66(18):9290-8. doi: 10.1158/0008-5472.CAN-06-1819. Cancer Res. 2006. PMID: 16982774

• Is damage in central nervous system due to inflammation?

  Chavarria A, Alcocer-Varela J. Chavarria A, et al. Autoimmun Rev. 2004 Jun;3(4):251-60. doi: 10.1016/j.autrev.2003.09.006. Autoimmun Rev. 2004. PMID: 15246020 Review.

• The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.

  Correale J, Villa A. Correale J, et al. Autoimmunity. 2007 Mar;40(2):148-60. doi: 10.1080/08916930601183522. Autoimmunity. 2007. PMID: 17453713 Review.

Cited by

• Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.

  Romme Christensen J, Börnsen L, Hesse D, Krakauer M, Sørensen PS, Søndergaard HB, Sellebjerg F. Romme Christensen J, et al. J Neuroinflammation. 2012 Sep 14;9:215. doi: 10.1186/1742-2094-9-215. J Neuroinflammation. 2012. PMID: 22978757 Free PMC article.

• Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.

  Romme Christensen J, Börnsen L, Ratzer R, Piehl F, Khademi M, Olsson T, Sørensen PS, Sellebjerg F. Romme Christensen J, et al. PLoS One. 2013;8(3):e57820. doi: 10.1371/journal.pone.0057820. Epub 2013 Mar 1. PLoS One. 2013. PMID: 23469245 Free PMC article.

• Blockage of indoleamine 2,3-dioxygenase regulates Japanese encephalitis via enhancement of type I/II IFN innate and adaptive T-cell responses.

  Kim SB, Choi JY, Uyangaa E, Patil AM, Hossain FM, Hur J, Park SY, Lee JH, Kim K, Eo SK. Kim SB, et al. J Neuroinflammation. 2016 Apr 18;13(1):79. doi: 10.1186/s12974-016-0551-5. J Neuroinflammation. 2016. PMID: 27090635 Free PMC article.

• Post-ischemic inflammation in the brain.

  Shichita T, Sakaguchi R, Suzuki M, Yoshimura A. Shichita T, et al. Front Immunol. 2012 May 31;3:132. doi: 10.3389/fimmu.2012.00132. eCollection 2012. Front Immunol. 2012. PMID: 22833743 Free PMC article.

• CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?

  Rezai-Zadeh K, Gate D, Town T. Rezai-Zadeh K, et al. J Neuroimmune Pharmacol. 2009 Dec;4(4):462-75. doi: 10.1007/s11481-009-9166-2. Epub 2009 Aug 11. J Neuroimmune Pharmacol. 2009. PMID: 19669892 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program